100% Original Products
Fast Delivery within 24-72 Hours
Cash On Delivery Available
24/7 Order Support via whatsapp
Moxaclav treats bacterial infections at these sites:
Respiratory: Pneumonia, bronchitis, sinusitis, tonsillitis, otitis media
GU Tract: Cystitis, pyelonephritis, urethritis
Skin/Soft Tissue: Cellulitis, abscesses
Systemic Infections: Septic abortion, intra-abdominal sepsis, osteomyelitis
*Not for viral infections. Minimum effective duration: 5-7 days.*
| Formulation | Amoxicillin | Clavulanic Acid | Use Case |
|---|---|---|---|
| Tablets | 250-875 mg | 125 mg | Adults & >12 years |
| Suspension (5mL) | 125 mg | 31.25 mg | Children 1-12 years |
| Forte Suspension (5mL) | 400 mg | 57.5 mg | Severe pediatric cases |
| IV Injection | 500-1000 mg | 100-200 mg | Hospital/severe cases |
Amoxicillin: Broad-spectrum penicillin → disrupts bacterial cell wall synthesis.
Clavulanate: β-lactamase inhibitor → protects amoxicillin from enzyme degradation.
Synergy: Extends coverage to β-lactamase-producing strains of:
S. aureus, H. influenzae, E. coli, Klebsiella
| Patient Group | Standard Dose | Severe Infection |
|---|---|---|
| Adults | 625 mg 12-hourly OR 375 mg 8-hourly | 1g 12-hourly OR 625 mg 8-hourly |
| Children 7-12y | Forte: 5mL 12-hourly | Forte: 10mL 12-hourly |
| Children 2-6y | Forte: 2.5mL 12-hourly | Forte: 5mL 12-hourly |
| Infants <1y | 25 mg/kg/day (amox) in 3 divided doses |
| Patient Group | Standard Dose | Severe Infection |
|---|---|---|
| Adults | 1.2g 8-hourly | 1.2g 6-hourly |
| Children >3mo | 30 mg/kg 8-hourly | 30 mg/kg 6-hourly |
| Surgical Prophylaxis | 1.2g pre-op → 1.2g 8-hourly (high-risk) |
Oral: Take at meal start to enhance absorption + reduce GI upset.
Suspension Prep:
Shake powder bottle
Add water to marked line
Shake until dissolved → refrigerate (use within 7 days)
IV Injection:
Reconstitute with 20mL Water for Injection
Administer over 3-4 min IV push or 30-min infusion
Never mix with: Dextrose, blood products, bicarbonate solutions
Penicillin allergy (cross-sensitivity with cephalosporins)
History of drug-induced cholestatic jaundice
Diarrhea (15%), nausea (10%), vaginal candidiasis (8%), rash (5%)
Clostridioides difficile colitis (watery/bloody stools)
Hepatotoxicity (monitor LFTs)
Anaphylaxis (have epinephrine available)
| Drug | Effect | Recommendation |
|---|---|---|
| Allopurinol | ↑ Risk of skin rash | Avoid concurrent use |
| Oral Contraceptives | Reduced efficacy | Use backup contraception |
| Warfarin | ↑ Bleeding risk (PT prolongation) | Monitor INR closely |
| Condition | Dosage Adjustment |
|---|---|
| Renal Impairment (CrCl <30 mL/min) | 375mg 12-hourly OR 1.2g IV → 0.6g IV 12-hourly |
| Hepatic Impairment | Avoid in severe disease |
| Pregnancy (Category B) | Use only if benefit > risk |
| Breastfeeding | Trace amounts in milk → monitor infant for diarrhea |
Symptoms: Severe nausea, electrolyte imbalance, crystalluria
Treatment: Hemodialysis + supportive care
Tablets/Suspension: Below 25°C, protected from moisture
Reconstituted IV: Use within 20 minutes (discard unused portion)
Oral Suspension: Refrigerate (2-8°C) → discard after 7 days
Medical Notice: Always complete full course. Not for prophylaxis except surgical.
Registered চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Your email address will not be published. Required fields are marked *
Please login to write review!
Looks like there are no reviews yet.
Comment